ArticleInflammatory bowel diseases2018
Predictors and Management of Loss of Response to Vedolizumab in Inflammatory Bowel Disease.
Eugenia Shmidt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
37 papers cite it
this paperpooled itcites it